Stonehearth Capital Management, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1550191 DANVERS, MA

Position in GILD

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$224,253

-$36,680 QoQ

Shares Held

1,775

-44.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.12%

of 13F equity value

Holder Rank

#1,853

of 2,266 holders

Holding Since

Sep 2023

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Stonehearth Capital Management, LLC holds $1,506,955 across 5 Drug Manufacturers - General names. GILD ranks #5 (14.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,920	$487,622
2	LLY	ELI LILLY & Co	250	$299,857
3	PFE	Pfizer Inc	10,448	$251,587
4	MRK	Merck & Co., Inc.	1,896	$243,636
5	GILD	Gilead Sciences, Inc. This page	1,775	$224,253

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$224,253	1,775	-44.9%	Shares	Sole	2026-07-07
2023-12-31	$260,933	3,221	+12.5%	Shares	Sole	2024-01-08
2023-09-30	$214,478	2,862	—	Shares	Sole	2023-10-11
No filing history on record for this holder in this stock.